Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8407 | 1187 | 46.5 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
313 | 17635 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | X LINKED AGAMMAGLOBULINEMIA | Author keyword | 113 | 67% | 9% | 101 |
2 | BRUTONS TYROSINE KINASE | Author keyword | 113 | 71% | 8% | 90 |
3 | BTK | Author keyword | 84 | 56% | 9% | 101 |
4 | XLA | Author keyword | 34 | 65% | 3% | 33 |
5 | BTK GENE | Author keyword | 31 | 92% | 1% | 12 |
6 | BRUTONS TYROSINE KINASE BTK | Author keyword | 21 | 71% | 1% | 17 |
7 | TEC KINASE | Author keyword | 19 | 76% | 1% | 13 |
8 | TEC KINASES | Author keyword | 15 | 82% | 1% | 9 |
9 | ITK | Author keyword | 14 | 34% | 3% | 33 |
10 | BRUTON TYROSINE KINASE | Author keyword | 14 | 65% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | X LINKED AGAMMAGLOBULINEMIA | 113 | 67% | 9% | 101 | Search X+LINKED+AGAMMAGLOBULINEMIA | Search X+LINKED+AGAMMAGLOBULINEMIA |
2 | BRUTONS TYROSINE KINASE | 113 | 71% | 8% | 90 | Search BRUTONS+TYROSINE+KINASE | Search BRUTONS+TYROSINE+KINASE |
3 | BTK | 84 | 56% | 9% | 101 | Search BTK | Search BTK |
4 | XLA | 34 | 65% | 3% | 33 | Search XLA | Search XLA |
5 | BTK GENE | 31 | 92% | 1% | 12 | Search BTK+GENE | Search BTK+GENE |
6 | BRUTONS TYROSINE KINASE BTK | 21 | 71% | 1% | 17 | Search BRUTONS+TYROSINE+KINASE+BTK | Search BRUTONS+TYROSINE+KINASE+BTK |
7 | TEC KINASE | 19 | 76% | 1% | 13 | Search TEC+KINASE | Search TEC+KINASE |
8 | TEC KINASES | 15 | 82% | 1% | 9 | Search TEC+KINASES | Search TEC+KINASES |
9 | ITK | 14 | 34% | 3% | 33 | Search ITK | Search ITK |
10 | BRUTON TYROSINE KINASE | 14 | 65% | 1% | 13 | Search BRUTON+TYROSINE+KINASE | Search BRUTON+TYROSINE+KINASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | X LINKED AGAMMAGLOBULINEMIA | 233 | 43% | 35% | 414 |
2 | BTK | 138 | 63% | 12% | 138 |
3 | BRUTONS TYROSINE KINASE | 102 | 31% | 23% | 278 |
4 | BTK GENE | 94 | 97% | 2% | 28 |
5 | TEC FAMILY | 79 | 71% | 5% | 64 |
6 | DEFICIENT EXPRESSION | 73 | 88% | 3% | 35 |
7 | PCI 32765 | 56 | 68% | 4% | 49 |
8 | TEC FAMILY KINASES | 52 | 58% | 5% | 61 |
9 | XLA | 50 | 86% | 2% | 25 |
10 | ITK | 28 | 51% | 3% | 39 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species | 2001 | 141 | 90 | 84% |
Targeting Bruton's tyrosine kinase in B cell malignancies | 2014 | 24 | 155 | 53% |
Tec family kinases in T lymphocyte development and function | 2005 | 160 | 206 | 67% |
Primary B Cell Immunodeficiencies: Comparisons and Contrasts | 2009 | 157 | 143 | 36% |
Bruton Tyrosine Kinase (BTK) and Its Role in B-cell Malignancy | 2012 | 52 | 111 | 53% |
Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling | 2005 | 111 | 101 | 71% |
Ibrutinib and novel BTK inhibitors in clinical development | 2013 | 26 | 62 | 71% |
New insights into the regulation and functions of Tec family tyrosine kinases in the immune system | 2002 | 59 | 65 | 77% |
Targets for Ibrutinib Beyond B Cell Malignancies | 2015 | 1 | 96 | 71% |
Signaling network of the Btk family kinases | 2000 | 105 | 107 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOL INFECT DIS PROGRAM | 3 | 30% | 0.8% | 9 |
2 | MOL IMMUNOL INFECT DIS | 2 | 12% | 1.6% | 19 |
3 | CHEM GENOM STRUCT BIOL | 2 | 67% | 0.2% | 2 |
4 | IMMUNOBIOL OPT INTEGRATED BIOSCI PROGRAM | 1 | 100% | 0.2% | 2 |
5 | WILLAMETTE VALLEY CANC | 1 | 50% | 0.2% | 2 |
6 | IMMUNOPHYSIOL SECT | 1 | 33% | 0.3% | 3 |
7 | JIANGSU MOL TARGETED ANTITUMOR DRUG | 1 | 22% | 0.3% | 4 |
8 | CLIN IMMUNOL MICROBIOL PATHOL INFECT DIS | 1 | 33% | 0.2% | 2 |
9 | PEDIAT IMMUNOL CLIN | 1 | 33% | 0.2% | 2 |
10 | PARKER HUGHES CANC | 1 | 12% | 0.5% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000130816 | SYK//SPLEEN TYROSINE KINASE//R788 |
2 | 0.0000116417 | SLP 76//LINKER FOR ACTIVATION OF T CELLS//SECT LYMPHOCYTE SIGNALING |
3 | 0.0000113903 | COMMON VARIABLE IMMUNODEFICIENCY//IGA DEFICIENCY//CVID |
4 | 0.0000110641 | RECEPTOR EDITING//SURROGATE LIGHT CHAIN//PRE B CELL RECEPTOR |
5 | 0.0000068945 | OMENN SYNDROME//SEVERE COMBINED IMMUNODEFICIENCY//T CELL LYMPHOPENIA |
6 | 0.0000060085 | VAV//VAV1//VAV3 |
7 | 0.0000057894 | SHIP2//INOSITOL 5 PHOSPHATASE//SHIP1 |
8 | 0.0000056414 | ARID3B//JUMONJI//AT RICH INTERACTION DOMAIN |
9 | 0.0000054304 | PHOSPHOLIPASE C DELTA 1//PHOSPHOLIPASE C GAMMA 1//GENOME BIOSIGNAL |
10 | 0.0000054178 | TOFACITINIB//JAK3//CP 690 550 |